<DOC>
	<DOCNO>NCT00094770</DOCNO>
	<brief_summary>The purpose investigational study determine safety effectiveness investigational drug patient type 2 diabetes mellitus ( specific type diabetes ) .</brief_summary>
	<brief_title>An Investigational Drug Study Patients With Type 2 Diabetes Mellitus ( 0431-024 )</brief_title>
	<detailed_description>The duration treatment 104 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Glipizide</mesh_term>
	<criteria>Patients least 18 year age old 78 type 2 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>